Physician

Sakeer Hussain, M.D.

According to 2025 Medicare claims, Sakeer Hussain, M.D. (NPI: 1952423071) practices hematology/oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 51503-4658. Hussain is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Maple ACO LLC (ACO ID: A5401), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Hussain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 672 traditional Medicare patients, billed 354,740 HCPCS/CPT codes, and received $5,038,507 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,867 prescription claims across 349 beneficiaries totaling $6,425,404 in drug costs, led by Revlimid (Lenalidomide). DME data shows 23 claims. Open Payments data shows 160 records totaling $18,691. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $743,386 to $5,038,507. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,367,472 to $6,425,404. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	539	98,359	$743,386
2016	519	110,383	$1,115,810
2017	561	130,176	$1,415,442
2018	504	134,418	$2,182,712
2019	619	128,532	$1,997,663
2020	705	221,721	$3,093,256
2021	709	220,538	$3,842,645
2022	712	301,541	$4,568,799
2023	728	252,371	$3,960,948
2024	672	354,740	$5,038,507

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,367	$1,367,472
2016	216	1,367	$1,656,596
2017	213	1,329	$1,954,236
2018	203	1,207	$1,969,061
2019	237	1,198	$2,716,362
2020	280	1,547	$4,538,307
2021	304	1,490	$4,637,036
2022	330	1,642	$5,141,696
2023	354	1,989	$4,603,035
2024	349	1,867	$6,425,404

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	40	457	$64,723
2016	N/R	114	$4,836
2017	N/R	34	$370
2018	N/R	N/R	N/R
2019	N/R	44	$3,190
2020	11	80	$8,774
2021	N/R	21	$388
2022	N/R	15	$282
2023	N/R	88	$8,892
2024	N/R	23	$414

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	710	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	529	867	$59
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	92	246	$41
36415	Insertion of needle into vein for collection of blood sample	485	1,466	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	432	1,785	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	87	2,289	$1,416,826
Ibrance	Palbociclib	71	1,988	$1,023,665
Brukinsa	Zanubrutinib	30	900	$448,088
Pomalyst	Pomalidomide	23	602	$426,127
Imbruvica	Ibrutinib	25	750	$371,233

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	23	$414

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$18,691	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sakeer Hussain, M.D.?

Tedicare shows public-source Medicare data for Sakeer Hussain, M.D. (NPI 1952423071), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sakeer Hussain, M.D. have ACO affiliation data?

Sakeer Hussain, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Sakeer Hussain, M.D.?

Sakeer Hussain, M.D. is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Sakeer Hussain, M.D. have Open Payments data?

Sakeer Hussain, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.